These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 15707577

  • 1. Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling.
    Inestrosa NC, Godoy JA, Quintanilla RA, Koenig CS, Bronfman M.
    Exp Cell Res; 2005 Mar 10; 304(1):91-104. PubMed ID: 15707577
    [Abstract] [Full Text] [Related]

  • 2. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.
    Fuentealba RA, Farias G, Scheu J, Bronfman M, Marzolo MP, Inestrosa NC.
    Brain Res Brain Res Rev; 2004 Dec 10; 47(1-3):275-89. PubMed ID: 15572177
    [Abstract] [Full Text] [Related]

  • 3. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
    Toledo EM, Inestrosa NC.
    Mol Psychiatry; 2010 Mar 10; 15(3):272-85, 228. PubMed ID: 19621015
    [Abstract] [Full Text] [Related]

  • 4. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
    De Ferrari GV, Chacón MA, Barría MI, Garrido JL, Godoy JA, Olivares G, Reyes AE, Alvarez A, Bronfman M, Inestrosa NC.
    Mol Psychiatry; 2003 Feb 10; 8(2):195-208. PubMed ID: 12610652
    [Abstract] [Full Text] [Related]

  • 5. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A, Benedetti E, Cristiano L, Sebastiani P, D'Amico MA, D'Angelo B, Di Loreto S.
    Neuroscience; 2005 Feb 10; 130(2):325-37. PubMed ID: 15664689
    [Abstract] [Full Text] [Related]

  • 6. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG.
    J Cell Biochem; 2005 Nov 01; 96(4):760-74. PubMed ID: 16149072
    [Abstract] [Full Text] [Related]

  • 7. Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling.
    Salins P, Shawesh S, He Y, Dibrov A, Kashour T, Arthur G, Amara F.
    Neurosci Lett; 2007 Feb 02; 412(3):211-6. PubMed ID: 17234346
    [Abstract] [Full Text] [Related]

  • 8. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
    Arthritis Rheum; 2005 Mar 02; 52(3):759-69. PubMed ID: 15751073
    [Abstract] [Full Text] [Related]

  • 9. Beta-amyloid oligomers affect the structure and function of the postsynaptic region: role of the Wnt signaling pathway.
    Dinamarca MC, Colombres M, Cerpa W, Bonansco C, Inestrosa NC.
    Neurodegener Dis; 2008 Mar 02; 5(3-4):149-52. PubMed ID: 18322375
    [Abstract] [Full Text] [Related]

  • 10. Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells.
    d'Abramo C, Ricciarelli R, Pronzato MA, Davies P.
    J Neurochem; 2006 Aug 02; 98(4):1068-77. PubMed ID: 16787414
    [Abstract] [Full Text] [Related]

  • 11. Frizzled-1 is involved in the neuroprotective effect of Wnt3a against Abeta oligomers.
    Chacón MA, Varela-Nallar L, Inestrosa NC.
    J Cell Physiol; 2008 Oct 02; 217(1):215-27. PubMed ID: 18521822
    [Abstract] [Full Text] [Related]

  • 12. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D, Seitz O, Goren I, Dissmann JP, Schmidt H, Bachmann M, Sader R, Geisslinger G, Pfeilschifter J, Frank S.
    Mol Pharmacol; 2008 Oct 02; 74(4):952-63. PubMed ID: 18599600
    [Abstract] [Full Text] [Related]

  • 13. Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance.
    Guo L, Tabrizchi R.
    Pharmacol Ther; 2006 Jul 02; 111(1):145-73. PubMed ID: 16305809
    [Abstract] [Full Text] [Related]

  • 14. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells.
    Zheng S, Chen A.
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan 02; 292(1):G113-23. PubMed ID: 16959952
    [Abstract] [Full Text] [Related]

  • 15. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway.
    Arrázola MS, Varela-Nallar L, Colombres M, Toledo EM, Cruzat F, Pavez L, Assar R, Aravena A, González M, Montecino M, Maass A, Martínez S, Inestrosa NC.
    J Cell Physiol; 2009 Dec 02; 221(3):658-67. PubMed ID: 19711354
    [Abstract] [Full Text] [Related]

  • 16. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM, Wright KL, Whittaker P, Chakravarty P, Watson ML, Ward SG.
    Cell Signal; 2005 Sep 02; 17(9):1098-110. PubMed ID: 15993751
    [Abstract] [Full Text] [Related]

  • 17. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
    Xiao J, Leung JC, Chan LY, Guo H, Lai KN.
    Nephrol Dial Transplant; 2009 Jul 02; 24(7):2067-77. PubMed ID: 19155534
    [Abstract] [Full Text] [Related]

  • 18. Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma.
    Li X, Yang X, Xu Y, Jiang X, Li X, Nan F, Tang H.
    Cell Res; 2009 Jun 02; 19(6):720-32. PubMed ID: 19417774
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ, Liu PQ, Lin DJ, Xiao RZ, Huang M, Li XD, He Y, Huang RW.
    Ann Hematol; 2007 Mar 02; 86(3):173-83. PubMed ID: 17089125
    [Abstract] [Full Text] [Related]

  • 20. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J, Morales M, Caelles C.
    Diabetes; 2007 Jul 02; 56(7):1865-71. PubMed ID: 17416798
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.